IDT-BT

5,5′-[[4,4,9,9-Tetrakis(4-hexylphenyl)-4,9-dihydro-s-indaceno[1,2-b:5,6-b′]dithiophene-2,7-diyl]bis(2,1,3-benzothiadiazole-7,4-diylmethylidyne)]bis[3-ethyl-2-thioxo-4-thiazolidinone], IDT-BT-R

IDT-C8-2CHO

IDT‐nC8

4,4,9,9-Tetrakis(4-hexylphenyl)-4,9-dihydro-s-indaceno[1,2-b:5,6-b']dithiophene-2,7-dicarbaldehyde

IC-BT-Br

RDN-BT-Br

6,7-Difluoro-2,3-dihydro-1,2-benzothiazol-3-one

N-methyl-1-[(1-methyl-1H-indol-2-yl)methyl]cyclopropan-1-amine

1-methyl-3-[1-(piperidin-4-yl)ethyl]-1H-indazole

2-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]morpholine

4-(Azetidin-3-yloxy)benzene-1,2,3-triol

3-[(4-Methoxypiperidin-4-yl)methyl]-4-methylpyridine

1-[(2,6-dimethoxyphenyl)methyl]-N-methylcyclopropan-1-amine

N,N-dimethyl-2-[1-(methylamino)cyclopropyl]aniline

2-Fluoro-3-[1-(piperidin-4-yl)ethyl]pyridine

[2-(2-Chloro-3,6-difluorophenyl)propan-2-yl](methyl)amine